Ealixir Aktsia

Ealixir P/B

P/B (hinna ja raamatupidamisliku väärtuse suhe) ettevõttest Ealixir (EAXR) seisuga 12. aug 2026 on −95,10. Eelmisel aastal oli P/B (hinna ja raamatupidamisliku väärtuse suhe) −65,28 — muutus 45,69% (madalam).

P/B

−95,10

YoY

45,69%

Viimati uuendatud:

P/B (hinna ja raamatupidamisliku väärtuse suhe) ettevõttest Ealixir on 2026 −95,10 . P/B (hinna ja raamatupidamisliku väärtuse suhe) ettevõttest Ealixir oli 2025 −65,28 . See väheneb 45,69% madalam võrreldes eelmise aastaga.
Access this data via the Eulerpool API

Ealixir Aktsiate analüüs

Mida Ealixir teeb? Ealixir Inc is a biotechnology company founded in 2012 by Dr. Nithin Rajan. Dr. Rajan earned his doctoral degree in biomedical science from the University of Ottawa and has over ten years of experience in the field of biomedical research. Ealixir Inc is an innovative firm specializing in the development of novel therapeutic technologies based on cell and proteomic research. Ealixir's goal is to help patients with serious or chronic illnesses by offering biological solutions that support the body's natural functions. Ealixir has developed the concept of "lifestyle medicine," aiming to develop treatments that not only combat diseases but also influence the patient's lifestyle to help them lead a healthier life. The company follows an integrative approach, combining the use of medications and other therapeutic approaches. Ealixir specializes in ingredients and technologies that have the potential to stimulate and activate the body to promote natural regenerative processes. One of Ealixir's significant products is the Arthritin system, which is used for the treatment of arthritis and pain. Arthritin utilizes a blend of pain relief, inflammation inhibitors, and regeneration promoters to effectively alleviate arthritis pain and reverse the damage caused by the disease to the joints. Ealixir is also a pioneer in the development of nano "in-minutes" technologies, where nanoparticles are used to actively transport active substances to specific target cells, thereby achieving results in minutes rather than hours. Another important product of Ealixir is Collagenix, a beauty product that uses a blend of collagen, vitamins, and minerals to improve skin structure and wrinkle depth. Ealixir also offers products for animal care and medicine. The company has developed a new product for wound care in pets using the Ealixir technology. The solution consists of antibacterial ingredients and promotes the growth of new tissue. Ealixir also focuses on researching dietary supplements that contribute to overall health and well-being. The company pays special attention to proteins, magnesium, and omega-3 fatty acids. The range includes CBD oil and support for restful sleep. Overall, Ealixir has established itself as a leading company in biomedical research and the development of innovative therapies. The company's products are at the forefront of technology and are developed and tested by a great team of researchers and scientists. The brand has experienced rapid growth in recent years and will undoubtedly achieve many successes in the future, benefiting both patients and animal lovers as well as people who value health and wellness. Ealixir on üks populaarsemaid ettevõtteid Eulpoolist.

Sageli esitatud küsimused Ealixir aktsia kohta

Ealixir P/B (hinna ja raamatupidamisliku väärtuse suhe) on 2026. aastal −95,10.

P/B (hinna ja raamatupidamisliku väärtuse suhe) ettevõttest Ealixir muutus −65,28 -st −95,10 -ks, mis vastab 45,69% muutusele. Väärtus on madalam kui eelmisel aastal.

Eulpoolist leiate P/B (hinna ja raamatupidamisliku väärtuse suhe) Ealixir täieliku ajaloolise arengu alates 2006. aastast – koos aastate väärtustega, graafikutega ja üksikasjalike analüüsidega.

Hinna ja raamatupidamisliku väärtuse suhe võrdleb ettevõtte turuhinda tema raamatupidamislikuga. Madal P/B võib näidata alakursiga aktsiat, samas kõrge P/B võib viidata ülehinnanguele või tugevatele kasvuootustele.

P/B = aktsiakurs / raamatupidamislik väärtus aktsia kohta

P/B (hinna ja raamatupidamisliku väärtuse suhe) hindamiseks on oluline võrrelda seda sama tööstuse ja sektori ettevõtetega. Eulpoolis leiate P/B (hinna ja raamatupidamisliku väärtuse suhe) jaoks otsesed tööstusesisesed võrdlused.

Hea väärtus varieerub tööstuse ja ettevõtte arenguetapi järgi. Eulpoolis saate P/B (hinna ja raamatupidamisliku väärtuse suhe) Ealixir võrrelda sektori konkurentidega ja tööstuse keskmisega, et hinnata selle atraktiivsust.

Access this data via the Eulerpool API

Hindamine — Ealixir

Kõik finantsnäitajad — Ealixir